Weiping Zou

Regulatory T-cell compartmentalization and trafficking.

Regulatory T cells, tumour immunity and immunotherapy.

B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma.

Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells.

Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis.

Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment.

Interleukin-2 administration alters the CD4+FOXP3+ T-cell pool and tumor trafficking in patients with ovarian carcinoma.

Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma.

Drugs designed to inhibit human p38 mitogen-activated protein kinase activation treat Toxoplasma gondii and Encephalitozoon cuniculi infection.

Inhibitory B7-family molecules in the tumour microenvironment.

Tumor-induced immune suppression of in vivo effector T-cell priming is mediated by the B7-H1/PD-1 axis and transforming growth factor beta.

Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis.

Cutting edge: IFN-gamma enables APC to promote memory Th17 and abate Th1 cell development.

Endogenous IL-17 contributes to reduced tumor growth and metastasis.

FOXP3 defines regulatory T cells in human tumor and autoimmune disease.

Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments.

Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions.

Modeling dynamic changes in type 1 diabetes progression: quantifying beta-cell variation after the appearance of islet-specific autoimmune responses.

Role of T cell TGFbeta signaling and IL-17 in allograft acceptance and fibrosis associated with chronic rejection.

Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice.

T(H)17 cells in tumour immunity and immunotherapy.

Prognostic significance of regulatory T cells in tumor.

A crucial role for host APCs in the induction of donor CD4+CD25+ regulatory T cell-mediated suppression of experimental graft-versus-host disease.

Th17 cells in cancer: help or hindrance?

T lymphocytes to IDO+ cells: check.

IL-17+ regulatory T cells in the microenvironments of chronic inflammation and cancer.

Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells.

Antigen-presenting cell (APC) subsets in ovarian cancer.

Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis.

Dual biological effects of the cytokines interleukin-10 and interferon-γ.

Deciphering the role of Th17 cells in human disease.

Human TH17 cells are long-lived effector memory cells.

Bone marrow and the control of immunity.

Interleukin-10 ablation promotes tumor development, growth, and metastasis.

Endogenous interleukin-10 constrains Th17 cells in patients with inflammatory bowel disease.

The B7 homologues and their receptors in hematologic malignancies.

Regulatory T cells in human ovarian cancer.

Regulatory T cells in the bone marrow microenvironment in patients with prostate cancer.

Th17 cells have stem cell-like features and promote long-term immunity.

Nine lives for TH9s?

Elevated serum IL-8 is associated with the presence of hepatocellular carcinoma and independently predicts survival.

T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment.

Effects of tumor irradiation on host T-regulatory cells and systemic immunity in the context of adoptive T-cell therapy in mice.

NF-κB inhibits osteogenic differentiation of mesenchymal stem cells by promoting β-catenin degradation.

Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2.

TLR2 mediates Helicobacter pylori-induced tolerogenic immune response in mice.

Synbindin in Extracellular Signal-Regulated Protein Kinase Spatial Regulation and Gastric Cancer Aggressiveness.

T cells and costimulation in cancer.

OCT1 is a determinant of synbindin-related ERK signalling with independent prognostic significance in gastric cancer.

IL-22(+)CD4(+) T cells promote colorectal cancer stemness via STAT3 transcription factor activation and induction of the methyltransferase DOT1L.

TMEFF2 deregulation contributes to gastric carcinogenesis and indicates poor survival outcome.

ArhGAP30 promotes p53 acetylation and function in colorectal cancer.

MiR-198 represses tumor growth and metastasis in colorectal cancer by targeting fucosyl transferase 8.

Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells.

Long noncoding RNA GAPLINC regulates CD44-dependent cell invasiveness and associates with poor prognosis of gastric cancer.

MiR-194 deregulation contributes to colorectal carcinogenesis via targeting AKT2 pathway.

Classification of current anticancer immunotherapies.

Myeloid cells in hepatocellular carcinoma.

Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies.

Consensus nomenclature for CD8+ T cell phenotypes in cancer.

Dendritic cells are stressed out in tumor.

Chemokines and cellular plasticity of ovarian cancer stem cells.

Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy.

Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction.

PRC2 Epigenetically Silences Th1-Type Chemokines to Suppress Effector T-Cell Trafficking in Colon Cancer.

Biological and pathological activities of interleukin-22.

PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations.

Hydrogel dual delivered celecoxib and anti-PD-1 synergistically improve antitumor immunity.

Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer.

LncRNA GClnc1 Promotes Gastric Carcinogenesis and May Act as a Modular Scaffold of WDR5 and KAT2A Complexes to Specify the Histone Modification Pattern.

Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling.

Th22 cells control colon tumorigenesis through STAT3 and Polycomb Repression complex 2 signaling.

Inflammatory regulatory T cells in the microenvironments of ulcerative colitis and colon carcinoma.

Synthetic RORγ agonists regulate multiple pathways to enhance antitumor immunity.

IL33 Promotes Colon Cancer Cell Stemness via JNK Activation and Macrophage Recruitment.

Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy.

ARID1A-mutated ovarian cancers depend on HDAC6 activity.

Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy.

Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor.

Hepatic neuregulin 4 signaling defines an endocrine checkpoint for steatosis-to-NASH progression.

Suppression of FIP200 and autophagy by tumor-derived lactate promotes naïve T cell apoptosis and affects tumor immunity.

Phenotype and tissue distribution of CD28H immune cell subsets.

The Role of Tumor Microenvironment in Cancer Immunotherapy.

Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression.

miR-508 Defines the Stem-like/Mesenchymal Subtype in Colorectal Cancer.

Mechanistic insights into cancer immunity and immunotherapy.

Understanding the tumor immune microenvironment (TIME) for effective therapy.

Priming of Adoptively Transferred T Cells with a RORγ Agonist Confers Durable Memory and Stemness .

Human Naive T Cells Express Functional CXCL8 and Promote Tumorigenesis.

Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer.

Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer.

Tumor-infiltrating T cells in epithelial ovarian cancer: predictors of prognosis and biological basis of immunotherapy.

Spatial and phenotypic immune profiling of metastatic colon cancer.

Tracking Macrophage Infiltration in a Mouse Model of Pancreatic Cancer with the Positron Emission Tomography Tracer [11C]PBR28.

CD4+ Tissue-resident Memory T Cells Expand and Are a Major Source of Mucosal Tumour Necrosis Factor α in Active Crohn's Disease.

CD8 T cells regulate tumour ferroptosis during cancer immunotherapy.

RORγ Agonists Enhance the Sustained Antitumor Activity through Intrinsic Tc17 Cytotoxicity and Tc1 Recruitment.

Immunotherapy in Ovarian Cancer.

Inhibition of ATM Increases Interferon Signaling and Sensitizes Pancreatic Cancer to Immune Checkpoint Blockade Therapy.

Mathematical Modeling of the Metastatic Colorectal Cancer Microenvironment Defines the Importance of Cytotoxic Lymphocyte Infiltration and Presence of PD-L1 on Antigen Presenting Cells.